Myeloablative Autologous Stem-Cell Transplantation for Severe SclerodermaKeith Sullivan, Daniel E. Furst, Maureen D. Mayes et al.|New England Journal of Medicine|2018Cited by 584
Comparative Outcomes of Donor Graft CD34<sup>+</sup> Selection and Immune Suppressive Therapy As Graft-Versus-Host Disease Prophylaxis for Patients With Acute Myeloid Leukemia in Complete Remission Undergoing HLA-Matched Sibling Allogeneic Hematopoietic Cell TransplantationMarcelo C. Pasquini, Robert J. Soiffer, Steven M. Devine et al.|Journal of Clinical Oncology|2012Cited by 157
Complement-mediated T-cell depletion of bone marrow: comparison of T10B9.1A-31 and Muromonab-Orthoclone OKT3Carolyn A. Keever-Taylor, B. Giesen, ANN CRAIG et al.|Cytotherapy|2001Cited by 21